NOVN stock forecast
Our latest prediction for Novan, Inc.'s stock price was made on the July 2, 2019 when the stock price was at 2.95$.
In the short term (2weeks), NOVN's stock price should underperform the market by -1.63%. During that period the price should oscillate between -12.21% and +16.47%.
In the medium term (3months), NOVN's stock price should underperform the market by -0.01%. During that period the price should oscillate between -27.05% and +43.41%.Get email alerts
Create a solid portfolio with NOVN
About Novan, Inc.
Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC.
At the moment the company generates 6M USD in revenues.
On its last earning announcement, the company reported a loss of -0.55$ per share.
The book value per share is 0.17$
Three months stock forecastJuly 2, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|